Journey Medical Corporation announced that the Company has entered into a credit facility with an affiliate of SWK Holdings Corporation providing for borrowings of up to $20 million. The Credit Facility provides for an initial term loan of $15 million that the Company intends to use to fund general corporate operations and commercial and DFD-29 product development initiatives. The Company also has the option to draw an additional tranche of $5 million under the Credit Facility, subject to the achievement of specified operational and financial metrics, in the twelve months following the date of the credit facility.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.51 USD | -0.57% | -4.88% | -39.06% |
May. 01 | Journey Medical Corporation Appoints Joseph M. Benesch as Chief Financial Officer | CI |
Mar. 21 | Transcript : Journey Medical Corporation, 2023 Earnings Call, Mar 21, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.06% | 70.1M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- DERM Stock
- News Journey Medical Corporation
- Journey Medical Corporation Secures Credit Facility with SWK Holdings for Up to $20 Million